PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
The data was presented virtually at the American Academy of Neurology annual meeting
But deliveries to the EU and Switzerland are not affected by the supply issues
Second indication for Sarclisa covers drug’s use in combination with another standard myeloma treatment
Decision prompted by the ‘evolving variant landscape’ in the US
PME talks to Roberto Ascione, Gualberto Gussoni and Giuseppe Recchia about the advancement of digital therapeutics in Italy
by Jonathan Andrew
By Amy Johnson
By Michael Bradley
By Ute E Schmidt
Pharmaceutical Market Europe - April 2021
Are virtual congresses here to stay? How Italy is moving forward with digital therapeutics, EU cross-border healthcare for rare diseases
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Kukathasan has spent over 15 years working at McCann Health
Why patient engagement is essential throughout the entire product life cycle
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....